Evidence map›Paper›PMID 27233303›Full record

ArticlePhysiological reports2016

Aging does not affect soluble guanylate cyclase redox state in mouse aortas.

Takashi Shimosato, Masashi Tawa, Hirotaka Iwasaki, Takeshi Imamura, Tomio Okamura

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Takashi ShimosatoDepartment of Pharmacology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Masashi TawaDepartment of Pharmacology, Shiga University of Medical Science, Otsu, Shiga, Japan tawa@belle.shiga-med.ac.jp.
Hirotaka IwasakiDepartment of Pharmacology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Takeshi ImamuraDepartment of Pharmacology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Tomio OkamuraDepartment of Pharmacology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Shiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is associated with endothelial dysfunction, defined as a reduction in nitric oxide (NO) bioavailability. Although the redox state of the NO acceptor soluble guanylate cyclase (sGC) is another determinant factor for its bioavailability and is disturbed by reactive oxygen species (ROS) known to be increased with age, it is unclear whether aging actually has an impact on vascular sGC redox equilibrium. Therefore, this study investigated this issue using two different types of compounds, the sGC stimulator BAY 41-2272 and the sGC activator BAY 60-2770. Plasma thiobarbituric acid-reactive substances (TBARS) levels were markedly higher in aged (19-20 months old) mice than in young (2-3 months old) mice, whereas superoxide levels in endothelium-denuded aortas were not different between the groups. The relaxant response of endothelium-denuded aortas to either BAY 41-2272 or BAY 60-2770 was identical in aged and young mice. In addition, the vascular cGMP production stimulated with BAY 41-2272 or BAY 60-2770 in aged mice was the same level as that in young mice. These findings suggest that aging accompanied by an increase in systemic oxidative stress does not affect vascular smooth muscle ROS generation and sGC redox equilibrium. Unless ROS are increased in vascular smooth muscle, the sGC redox equilibrium might remain unchanged.

Indexed as

AgingAnimalsAorta, ThoracicBenzoatesBiphenyl CompoundsGuanylate CyclaseHydrocarbons, FluorinatedMaleMiceOrgan Culture TechniquesOxidation-ReductionPyrazolesPyridinesReceptors, Cytoplasmic and NuclearSoluble Guanylyl Cyclase3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acidBenzoatesBiphenyl CompoundsGuanylate CyclaseHydrocarbons, FluorinatedPyrazolesPyridinesReceptors, Cytoplasmic and NuclearSoluble Guanylyl CyclaseAgingnitric oxidesGC activatorsGC stimulatorsoluble guanylate cyclase

Identifiers

PMID27233303
PMCPMC4886176
OpenAlexW2397065904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.